Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

Next-generation sequencing (NGS) has reached the molecular diagnostic laboratories. Although the NGS technology aims to improve the effectiveness of therapies by selecting the most promising therapy, concerns are that NGS testing is expensive and that the ‘benefits’ are not yet in relation to these...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ecancermedicalscience
Главные авторы: van Amerongen, Rosa A, Retèl, Valesca P, Coupé, Veerle MH, Nederlof, Petra M, Vogel, Maartje J, van Harten, Wim H
Формат: Artigo
Язык:Inglês
Опубликовано: Cancer Intelligence 2016
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5102690/
https://ncbi.nlm.nih.gov/pubmed/27899957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.684
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы